Tech Center 1600 • Art Units: 1600 1675
This examiner grants 0% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18331475 | CANINE CANCER VACCINE | Non-Final OA | Arizona Board of Regents on behalf of Arizona State University |
| 18276871 | METHODS OF TREATING HYPOGONADOTROPIC HYPOGONADISM AND COGNITION IMPAIRMENT FOLLOWING A TRAUMATIC BRAIN INJURY | Non-Final OA | UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS |
| 18283385 | MULTISPECIFIC PROTEINS COMPRISING AN NKP46-BINDING SITE, A CANCER ANTGIENGE BINDING SITE FUSED TO A CYTOKINE FOR NK CELL ENGAGING | Non-Final OA | INNATE PHARMA |
| 18201626 | USE OF ANTI-IL-27 ANTIBODIES | Non-Final OA | F. HOFFMANN-LA ROCHE AG |
| 18035837 | COMPOSITIONS OF EMBEDDED EPITOPE RANDOM PEPTIDES (EERP) FOR TREATMENT OF IMMUNE-MEDIATED CONDITIONS, AND METHODS OF USE | Non-Final OA | PALENA THERAPEUTICS, INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy